Tele: 561.316.3330
Breaking Medical Device News

Thursday, September 23, 2021

HomeA Breakthrough in Tinnitus Therapy

A Breakthrough in Tinnitus Therapy

Resaphene Suisse AG Reports a Breakthrough in Tinnitus Therapy

With the publication in the specialist magazine for complementary medicine 06/2018 informed Johannes Ebbers from Düren (Germany) on the results of his clinical user observation with the tinnitus therapy device tinniwell.

Since 2016 Resaphene Suisse AG (Vienna Stock Exchange: CH0367465439) sells the tinniwell. The device can be used by the patient in the home environment or even mobile. It combines the approach of heat and music therapy in a device, which was registered for a patent. In addition, it can determine the exact frequency of tinnitus in the patient. Competitors who work with apps are usually only able to do this on an indicative basis, which is why the therapy does not succeed there.

Between October 2016 and July 2017, 30 patients with chronic decompensated tinnitus were recruited. The subjects in the study were between 17 and 72 years old and had previously undergone various examinations (e.g., otoneurological evaluation); Exclusion criterion was for example an organic cause of tinnitus.

At the start of the therapy, the participants determined the severity of tinnitus using the Göbel and Hiller mini-questionaire. During the four-week therapy period, the tinniwell should be used for at least 30 minutes daily, and light activities such as reading and so on were permitted.

After 6 weeks at the latest, the tinnitus severity was again determined in the patients. 1 participant broke off without giving reasons, which allowed to collect the data from 29 participants. On average, tinnitus decreased by 54.1%. The range of results was between 100% (complete relief) and 20% improvement.

The study is available here.

“The results of user observation encourage us to conduct a double-blind study in the next step,” says Anke Rauterkus, CEO of Resaphene Suisse AG. “The key to the success of the therapy is the combination of warmth and frequency-filtered music. Meanwhile, the prototype for the third series of tinniwell has been developed. The new generation of devices is considerably smaller and will have interfaces to smartphones and other devices in the future.”

Medical Device News Magazine
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected


Don't Miss

Kleiner Device Labs Receives FDA Market Clearance for KG2 Surge Flow-Thru Interbody System

The system maximizes total bone graft delivery volume, better distributes graft bilaterally into the intervertebral disc space, and streamlines the implant delivery, positioning, and grafting process for TLIF and PLIF spinal fusion procedures.

Shannon Lantzy MedCrypt New VP of Consulting

"I met Shannon at a healthcare-related event several years ago and was immediately impressed with her passion and drive to move healthcare into a digital future," said Mike Kijewski, CEO of MedCrypt.

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

By using this website you agree to accept Medical Device News Magazine Privacy Policy